iκb kinase Search Results


94
Proteintech anti ikkα
Anti Ikkα, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/i%CE%BAb+kinase/IKBKB+Antibody/pmc11292531-164-23-24
Average 94 stars, based on 1 article reviews
anti ikkα - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

90
Merck KGaA iκb kinase (ikk) inhibitor parthenolide
( A ) RAW264.7 cells were exposed for 1 hr to 50 μg/ml oxLDL with or without pre-treatment with the JMJD inhibitor JIB-04 for 4 hrs, after which Western blot analysis was carried out to monitor expression of the indicated proteins. ( B ) RAW264.7 cells transfected with shKDM4A and scramble control shRNA were exposed to 50 μg/ml oxLDL for 1 hr, after which expression of HIF-1α, -1β, and phosphorylated p65 (S536) was monitored by Western blot analysis. ( C ) RAW264.7 cells were exposed for 1 hr to 50 μg/ml oxLDL with or without pre-treatment with the <t>IKK</t> inhibitor <t>parthenolide</t> (PTL) for 2 hrs, after which expression of phosphorylated p65 and KDM4A was assessed by Western blot analysis. ( D ) RAW264.7 cells were transiently transfected with pGreenpuro-shRNA constructs specifically targeting HIF-1β (shHIF-1β-1 and -2) or scrambled sequence as control. Down-regulation of HIF-1β was validated by Western blot analysis (upper panel). Cells were then exposed to 50 μg/ml oxLDL for 1 hr, after which expression of KDM4A was monitored by Western blot analysis.
Iκb Kinase (Ikk) Inhibitor Parthenolide, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/i%CE%BAb+kinase/i%CE%BAb+kinase++ikk++inhibitor+parthenolide/pmc05777704-180-1-21
Average 90 stars, based on 1 article reviews
iκb kinase (ikk) inhibitor parthenolide - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Schmid GmbH iκb kinase ε
( A ) RAW264.7 cells were exposed for 1 hr to 50 μg/ml oxLDL with or without pre-treatment with the JMJD inhibitor JIB-04 for 4 hrs, after which Western blot analysis was carried out to monitor expression of the indicated proteins. ( B ) RAW264.7 cells transfected with shKDM4A and scramble control shRNA were exposed to 50 μg/ml oxLDL for 1 hr, after which expression of HIF-1α, -1β, and phosphorylated p65 (S536) was monitored by Western blot analysis. ( C ) RAW264.7 cells were exposed for 1 hr to 50 μg/ml oxLDL with or without pre-treatment with the <t>IKK</t> inhibitor <t>parthenolide</t> (PTL) for 2 hrs, after which expression of phosphorylated p65 and KDM4A was assessed by Western blot analysis. ( D ) RAW264.7 cells were transiently transfected with pGreenpuro-shRNA constructs specifically targeting HIF-1β (shHIF-1β-1 and -2) or scrambled sequence as control. Down-regulation of HIF-1β was validated by Western blot analysis (upper panel). Cells were then exposed to 50 μg/ml oxLDL for 1 hr, after which expression of KDM4A was monitored by Western blot analysis.
Iκb Kinase ε, supplied by Schmid GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/i%CE%BAb+kinase/i%CE%BAb+kinase+%CE%B5/pm32650099-659-11-5
Average 90 stars, based on 1 article reviews
iκb kinase ε - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Baiao Pharmaceuticals p-iκb kinase α antibody
( A ) RAW264.7 cells were exposed for 1 hr to 50 μg/ml oxLDL with or without pre-treatment with the JMJD inhibitor JIB-04 for 4 hrs, after which Western blot analysis was carried out to monitor expression of the indicated proteins. ( B ) RAW264.7 cells transfected with shKDM4A and scramble control shRNA were exposed to 50 μg/ml oxLDL for 1 hr, after which expression of HIF-1α, -1β, and phosphorylated p65 (S536) was monitored by Western blot analysis. ( C ) RAW264.7 cells were exposed for 1 hr to 50 μg/ml oxLDL with or without pre-treatment with the <t>IKK</t> inhibitor <t>parthenolide</t> (PTL) for 2 hrs, after which expression of phosphorylated p65 and KDM4A was assessed by Western blot analysis. ( D ) RAW264.7 cells were transiently transfected with pGreenpuro-shRNA constructs specifically targeting HIF-1β (shHIF-1β-1 and -2) or scrambled sequence as control. Down-regulation of HIF-1β was validated by Western blot analysis (upper panel). Cells were then exposed to 50 μg/ml oxLDL for 1 hr, after which expression of KDM4A was monitored by Western blot analysis.
P Iκb Kinase α Antibody, supplied by Baiao Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/i%CE%BAb+kinase/p+i%CE%BAb+kinase+%CE%B1+antibody/pmc08026846-49-0-6
Average 90 stars, based on 1 article reviews
p-iκb kinase α antibody - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Assay Biotechnology anti-iκb kinase (ikk; ser 180 /ser 181 ) rabbit pab
( A ) RAW264.7 cells were exposed for 1 hr to 50 μg/ml oxLDL with or without pre-treatment with the JMJD inhibitor JIB-04 for 4 hrs, after which Western blot analysis was carried out to monitor expression of the indicated proteins. ( B ) RAW264.7 cells transfected with shKDM4A and scramble control shRNA were exposed to 50 μg/ml oxLDL for 1 hr, after which expression of HIF-1α, -1β, and phosphorylated p65 (S536) was monitored by Western blot analysis. ( C ) RAW264.7 cells were exposed for 1 hr to 50 μg/ml oxLDL with or without pre-treatment with the <t>IKK</t> inhibitor <t>parthenolide</t> (PTL) for 2 hrs, after which expression of phosphorylated p65 and KDM4A was assessed by Western blot analysis. ( D ) RAW264.7 cells were transiently transfected with pGreenpuro-shRNA constructs specifically targeting HIF-1β (shHIF-1β-1 and -2) or scrambled sequence as control. Down-regulation of HIF-1β was validated by Western blot analysis (upper panel). Cells were then exposed to 50 μg/ml oxLDL for 1 hr, after which expression of KDM4A was monitored by Western blot analysis.
Anti Iκb Kinase (Ikk; Ser 180 /Ser 181 ) Rabbit Pab, supplied by Assay Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/i%CE%BAb+kinase/anti+i%CE%BAb+kinase++ikk++ser+180++ser+181+++rabbit+pab/pmc04124013-33-1-14
Average 90 stars, based on 1 article reviews
anti-iκb kinase (ikk; ser 180 /ser 181 ) rabbit pab - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Proteogen Inc small molecule inhibitors of iκb kinase β
( A ) RAW264.7 cells were exposed for 1 hr to 50 μg/ml oxLDL with or without pre-treatment with the JMJD inhibitor JIB-04 for 4 hrs, after which Western blot analysis was carried out to monitor expression of the indicated proteins. ( B ) RAW264.7 cells transfected with shKDM4A and scramble control shRNA were exposed to 50 μg/ml oxLDL for 1 hr, after which expression of HIF-1α, -1β, and phosphorylated p65 (S536) was monitored by Western blot analysis. ( C ) RAW264.7 cells were exposed for 1 hr to 50 μg/ml oxLDL with or without pre-treatment with the <t>IKK</t> inhibitor <t>parthenolide</t> (PTL) for 2 hrs, after which expression of phosphorylated p65 and KDM4A was assessed by Western blot analysis. ( D ) RAW264.7 cells were transiently transfected with pGreenpuro-shRNA constructs specifically targeting HIF-1β (shHIF-1β-1 and -2) or scrambled sequence as control. Down-regulation of HIF-1β was validated by Western blot analysis (upper panel). Cells were then exposed to 50 μg/ml oxLDL for 1 hr, after which expression of KDM4A was monitored by Western blot analysis.
Small Molecule Inhibitors Of Iκb Kinase β, supplied by Proteogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/i%CE%BAb+kinase/small+molecule+inhibitors+of+i%CE%BAb+kinase+%CE%B2/pm32205046-68-16-52
Average 90 stars, based on 1 article reviews
small molecule inhibitors of iκb kinase β - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
ActivX Inc small-molecule inhibitors of iκb kinase (ikk) & ikk-related kinases
( A ) RAW264.7 cells were exposed for 1 hr to 50 μg/ml oxLDL with or without pre-treatment with the JMJD inhibitor JIB-04 for 4 hrs, after which Western blot analysis was carried out to monitor expression of the indicated proteins. ( B ) RAW264.7 cells transfected with shKDM4A and scramble control shRNA were exposed to 50 μg/ml oxLDL for 1 hr, after which expression of HIF-1α, -1β, and phosphorylated p65 (S536) was monitored by Western blot analysis. ( C ) RAW264.7 cells were exposed for 1 hr to 50 μg/ml oxLDL with or without pre-treatment with the <t>IKK</t> inhibitor <t>parthenolide</t> (PTL) for 2 hrs, after which expression of phosphorylated p65 and KDM4A was assessed by Western blot analysis. ( D ) RAW264.7 cells were transiently transfected with pGreenpuro-shRNA constructs specifically targeting HIF-1β (shHIF-1β-1 and -2) or scrambled sequence as control. Down-regulation of HIF-1β was validated by Western blot analysis (upper panel). Cells were then exposed to 50 μg/ml oxLDL for 1 hr, after which expression of KDM4A was monitored by Western blot analysis.
Small Molecule Inhibitors Of Iκb Kinase (Ikk) & Ikk Related Kinases, supplied by ActivX Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/i%CE%BAb+kinase/small+molecule+inhibitors+of+i%CE%BAb+kinase++ikk++++ikk+related+kinases/pm24237125-176-13-18
Average 90 stars, based on 1 article reviews
small-molecule inhibitors of iκb kinase (ikk) & ikk-related kinases - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


( A ) RAW264.7 cells were exposed for 1 hr to 50 μg/ml oxLDL with or without pre-treatment with the JMJD inhibitor JIB-04 for 4 hrs, after which Western blot analysis was carried out to monitor expression of the indicated proteins. ( B ) RAW264.7 cells transfected with shKDM4A and scramble control shRNA were exposed to 50 μg/ml oxLDL for 1 hr, after which expression of HIF-1α, -1β, and phosphorylated p65 (S536) was monitored by Western blot analysis. ( C ) RAW264.7 cells were exposed for 1 hr to 50 μg/ml oxLDL with or without pre-treatment with the IKK inhibitor parthenolide (PTL) for 2 hrs, after which expression of phosphorylated p65 and KDM4A was assessed by Western blot analysis. ( D ) RAW264.7 cells were transiently transfected with pGreenpuro-shRNA constructs specifically targeting HIF-1β (shHIF-1β-1 and -2) or scrambled sequence as control. Down-regulation of HIF-1β was validated by Western blot analysis (upper panel). Cells were then exposed to 50 μg/ml oxLDL for 1 hr, after which expression of KDM4A was monitored by Western blot analysis.

Journal: Oncotarget

Article Title: Identification of the histone lysine demethylase KDM4A/JMJD2A as a novel epigenetic target in M1 macrophage polarization induced by oxidized LDL

doi: 10.18632/oncotarget.17748

Figure Lengend Snippet: ( A ) RAW264.7 cells were exposed for 1 hr to 50 μg/ml oxLDL with or without pre-treatment with the JMJD inhibitor JIB-04 for 4 hrs, after which Western blot analysis was carried out to monitor expression of the indicated proteins. ( B ) RAW264.7 cells transfected with shKDM4A and scramble control shRNA were exposed to 50 μg/ml oxLDL for 1 hr, after which expression of HIF-1α, -1β, and phosphorylated p65 (S536) was monitored by Western blot analysis. ( C ) RAW264.7 cells were exposed for 1 hr to 50 μg/ml oxLDL with or without pre-treatment with the IKK inhibitor parthenolide (PTL) for 2 hrs, after which expression of phosphorylated p65 and KDM4A was assessed by Western blot analysis. ( D ) RAW264.7 cells were transiently transfected with pGreenpuro-shRNA constructs specifically targeting HIF-1β (shHIF-1β-1 and -2) or scrambled sequence as control. Down-regulation of HIF-1β was validated by Western blot analysis (upper panel). Cells were then exposed to 50 μg/ml oxLDL for 1 hr, after which expression of KDM4A was monitored by Western blot analysis.

Article Snippet: The IκB kinase (IKK) inhibitor parthenolide [ ] and the pan-selective Jumonji histone demethylase inhibitor JIB-04 [ ] were purchased from Merck Millipore (Billerica, MA).

Techniques: Western Blot, Expressing, Transfection, Control, shRNA, Construct, Sequencing